• Phanes Therapeutics' PT217 receives Orphan Drug Designation for small cell lung cancer from the FDA

    12 days ago - By San Diego Biotechnology

    SAN DIEGO, June 21, 2022 /PRNewswire/ - Phanes Therapeutics, Inc. , an emerging leader in innovative discovery research and clinical development in oncology, announced today that the U.S. Food and Drug Administration has granted...
    Read more ...

     

  • DERMALA, A Consumer Dermatology Company, Announces Issuance of the 4th U.S. Patent Covering Human Microbiome to Treat and Prevent Eczema

    12 days ago - By San Diego Biotechnology

    SAN DIEGO, June 21, 2022 /PRNewswire/ - DERMALA Inc., a science-based consumer dermatology company developing novel, microbiome-based solutions for chronic skin conditions, announced today the issuance of the U.S. Patent No. 11,364,214 - COMPOSITIONS AND...
    Read more ...